Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 8 de 8
Filtrar
1.
Br J Nutr ; 112(9): 1542-50, 2014 Nov 14.
Artículo en Inglés | MEDLINE | ID: mdl-25230741

RESUMEN

Elevated postprandial hyperglycaemia and oxidative stress increase the risks of type 2 diabetes and CVD. Green tea catechin possesses antidiabetic properties and antioxidant capacity. In the present study, we examined the acute and continuous effects of ingestion of catechin-rich green tea on postprandial hyperglycaemia and oxidative stress in healthy postmenopausal women. Participants were randomly assigned into the placebo (P, n 11) or green tea (GT, n 11) group. The GT group consumed a catechin-rich green tea (catechins 615 mg/350 ml) beverage per d for 4 weeks. The P group consumed a placebo (catechins 92 mg/350 ml) beverage per d for 4 weeks. At baseline and after 4 weeks, participants of each group consumed their designated beverages with breakfast and consumed lunch 3 h after breakfast. Venous blood samples were collected in the fasted state (0 h) and at 2, 4 and 6 h after breakfast. Postprandial glucose concentrations were 3 % lower in the GT group than in the P group (three-factor ANOVA, group × time interaction, P< 0·05). Serum concentrations of the derivatives of reactive oxygen metabolites increased after meals (P< 0·05), but no effect of catechin-rich green tea intake was observed. Conversely, serum postprandial thioredoxin concentrations were 5 % higher in the GT group than in the P group (three-factor ANOVA, group × time interaction, P< 0·05). These findings indicate that an acute ingestion of catechin-rich green tea has beneficial effects on postprandial glucose and redox homeostasis in postmenopausal women.


Asunto(s)
Glucemia/análisis , Catequina/administración & dosificación , Posmenopausia/sangre , Periodo Posprandial , , Tiorredoxinas/sangre , Anciano , Método Doble Ciego , Ejercicio Físico , Ayuno , Femenino , Humanos , Persona de Mediana Edad , Estrés Oxidativo/efectos de los fármacos , Placebos , Especies Reactivas de Oxígeno/sangre
2.
Int J Sports Med ; 35(6): 469-75, 2014 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-24165958

RESUMEN

The purpose of this study was to investigate the effects of curcumin supplementation on exercise-induced oxidative stress in humans. 10 male participants, ages 26.8±2.0 years (mean±SE), completed 3 trials in a random order: (1) placebo (control), (2) single (only before exercise) and (3) double (before and immediately after exercise) curcumin supplementation trials. Each participant received oral administration of 90 mg of curcumin or the placebo 2h before exercise and immediately after exercise. Each participant walked or ran at 65% of V˙2max on a treadmill for 60min. Blood samples were collected pre-exercise, immediately after exercise and 2h after exercise. The concentrations of serum derivatives of reactive oxygen metabolites measured immediately after exercise were significantly higher than pre-exercise values in the placebo trial (308.8±12.9 U. CARR, P<0.05), but not in the single (259.9±17.1 U. CARR) or double (273.6±19.7 U. CARR) curcumin supplementation trials. Serum biological antioxidant potential concentrations measured immediately after exercise were significantly elevated in the single and double curcumin supplementation trials compared with pre-exercise values (P<0.05). These findings indicate that curcumin supplementation can attenuate exercise-induced oxidative stress by increasing blood antioxidant capacity.


Asunto(s)
Curcumina/administración & dosificación , Suplementos Dietéticos , Ejercicio Físico/fisiología , Estrés Oxidativo , Administración Oral , Adulto , Catalasa/sangre , Curcumina/metabolismo , Método Doble Ciego , Glutatión/sangre , Glutatión Peroxidasa/sangre , Glutatión Reductasa/sangre , Frecuencia Cardíaca , Humanos , Masculino , Percepción , Esfuerzo Físico , Especies Reactivas de Oxígeno/sangre , Superóxido Dismutasa/sangre , Sustancias Reactivas al Ácido Tiobarbitúrico/metabolismo , Tiorredoxinas/sangre , Adulto Joven
3.
J Nutr Sci Vitaminol (Tokyo) ; 59(5): 375-83, 2013.
Artículo en Inglés | MEDLINE | ID: mdl-24418871

RESUMEN

The purpose of this study was to investigate the effects of low-volume exercise training (90 min/wk) and vitamin E supplementation on oxidative stress markers in postmenopausal women. The participants were non-randomly assigned the following four groups: control (C, n=8), vitamin E (S, n=8), exercise (Ex, n=6), or vitamin E and exercise (S+Ex, n=7). The S and S+Ex groups were instructed to take vitamin E (α-tocopherol, 300 mg/d) capsules for 12 wk. The exercise program of Ex and S+Ex groups consisted of walking for a 30-60 min/session 2 d per week for 12 wk. The serum derivatives of reactive oxygen metabolites concentrations were significantly decreased in the Ex, and S+Ex groups after 12 wk compared with the baseline values (three-factor ANOVA, an interaction between exercise and time, p<0.05). Conversely, serum biological antioxidant potential concentrations in the S and Ex groups were significantly higher at 12 wk than at the baseline, but not in the S+Ex group (three-factor ANOVA, an interaction between supplementation, exercise and time, p<0.05). Plasma thioredoxin concentrations in the S, Ex, and S+Ex groups were significantly higher at 12 wk than at the baseline values (three-factor ANOVA, interactions between exercise and time, and between supplementation, exercise and time, p<0.05). Our findings suggest that low-volume physical activity may improve resting oxidative stress status in postmenopausal women.


Asunto(s)
Envejecimiento , Antioxidantes/uso terapéutico , Enfermedades Cardiovasculares/prevención & control , Suplementos Dietéticos , Ejercicio Físico , Estrés Oxidativo , Vitamina E/uso terapéutico , Anciano , Antioxidantes/análisis , Biomarcadores/sangre , Enfermedades Cardiovasculares/sangre , Enfermedades Cardiovasculares/epidemiología , Femenino , Promoción de la Salud , Humanos , Japón/epidemiología , Persona de Mediana Edad , Posmenopausia , Especies Reactivas de Oxígeno/antagonistas & inhibidores , Especies Reactivas de Oxígeno/sangre , Riesgo , Tiorredoxinas/agonistas , Tiorredoxinas/sangre , Caminata , alfa-Tocoferol/administración & dosificación , alfa-Tocoferol/sangre
4.
Thromb Haemost ; 108(3): 435-42, 2012 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-22836558

RESUMEN

Oxidative stress is involved in the chronic pathological vascular remodelling of both abdominal aortic aneurysm and occlusive atherosclerosis. Red blood cells (RBCs), leukocytes and platelets present in both, aneurysmal intraluminal thrombus and intraplaque haemorraghes, could be involved in the redox imbalance inside diseased arterial tissues. RBCs haemolysis may release the pro-oxidant haemoglobin (Hb), which transfers heme to tissue and low-density lipoproteins. Heme-iron potentiates molecular, cell and tissue toxicity mediated by leukocytes and other sources of reactive oxygen species (ROS). Polymorphonuclear neutrophils release myeloperoxidase and, along with activated platelets, produce superoxide mediated by NADPH oxidase, causing oxidative damage. In response to this pro-oxidant milieu, several antioxidant molecules of plasma or cell origin can prevent ROS production. Free Hb binds to haptoglobin (Hp) and once Hp-Hb complex is endocytosed by CD163, liberated heme is converted into less toxic compounds by heme oxygenase-1. Iron homeostasis is mainly regulated by transferrin, which transports ferric ions to other cells. Transferrin-bound iron is internalised via endocytosis mediated by transferrin receptor. Once inside the cell, iron is mainly stored by ferritin. Other non hemo-iron related antioxidant enzymes (e.g. superoxide dismutase, catalase, thioredoxin and peroxiredoxin) are also involved in redox modulation in vascular remodelling. Oxidative stress is a main determinant of chronic pathological remodelling of the arterial wall, partially linked to the presence of RBCs, leukocytes, platelets and oxidised fibrin within tissue and to the imbalance between pro-/anti-oxidant molecules. Understanding the complex mechanisms underlying redox imbalance could help to define novel potential targets to decrease atherothrombotic risk.


Asunto(s)
Plaquetas/metabolismo , Eritrocitos/metabolismo , Leucocitos/metabolismo , Estrés Oxidativo , Animales , Antígenos CD/sangre , Antígenos de Diferenciación Mielomonocítica/sangre , Antioxidantes/uso terapéutico , Aneurisma de la Aorta Abdominal/sangre , Aneurisma de la Aorta Abdominal/tratamiento farmacológico , Aterosclerosis/sangre , Aterosclerosis/tratamiento farmacológico , Catalasa/sangre , Terapia por Quelación , Endotelio Vascular/metabolismo , Endotelio Vascular/patología , Haptoglobinas/metabolismo , Hemo/metabolismo , Hemo-Oxigenasa 1/sangre , Humanos , Hierro/sangre , Peroxidasa/sangre , Peroxirredoxinas/sangre , Activación Plaquetaria , Especies Reactivas de Oxígeno/metabolismo , Receptores de Superficie Celular/sangre , Estallido Respiratorio , Superóxido Dismutasa/sangre , Tiorredoxinas/sangre
5.
J Biol Regul Homeost Agents ; 25(1): 37-45, 2011.
Artículo en Inglés | MEDLINE | ID: mdl-21382272

RESUMEN

The aim of this study is to gain further insights into the possible nutraceutical effect on redox balance via thioredoxin (Trx) modulation and on the intrinsic susceptibility of monocytes to generate an inflammatory response. The study group consisted of thirty-two patients with compensated Child A-C, HCV-related cirrhosis. The patients were supplemented for 6 months with 6g/day of a certified fermented papaya preparation (FPP). Fifteen unsupplemented, age/gender-matched healthy subjects served as controls. The patients filled in a detailed diet-life style questionnaire, and blood samples were collected to test routine biochemistry, Trx, redox status (GSH, GSSG, GSH/GSSG ratio, 4-HNE and alpha-tocopherol). Moreover, isolated monocytes were tested for ex-vivo LPS-stimulated TNF-alpha production and TNF-alpha mRNA. As compared to control, patients with liver cirrhosis showed a significantly higher serum level of Trx. A significant correlation occurred with GSH/GSSG ratio in Child B and C patients. FPP supplementation brought about a significant reduction of Trx with levels comparable to the ones of healthy controls. Ten patients Child C (31.2 percent) showed borderline low levels of alpha-tocopherol while all cirrhotic patients, as a whole, showed a significantly abnormal redox balance. Supplementation with FPP did not modify alpha-tocopherol depletion but significantly improved redox balance parameters. Patients with liver cirrhosis showed a significantly upregulated TNF-alpha production in a time-dependent manner and this effect was more pronounced in more advanced stages of the disease and showed a significant correlation with alpha-tocopherol level. Supplementation with FPP significantly, although partially, downregulated TNF-alpha production from monocytes. Taken altogether, it would appear that the typical oxidative-inflammatory biochemical milieu of these patients is mirrored by a significant TNF-alpha upregulation at a monocyte level while a targeted nutraceutical might be a potentially amenable intervention to be part of validated scheduled treatments.


Asunto(s)
Antioxidantes/administración & dosificación , Carica , Suplementos Dietéticos , Cirrosis Hepática/sangre , Transducción de Señal/efectos de los fármacos , Tiorredoxinas/sangre , Factor de Necrosis Tumoral alfa/sangre , Anciano , Femenino , Glutatión/sangre , Hepatitis B/sangre , Hepatitis C/sangre , Humanos , Masculino , Persona de Mediana Edad , Monocitos/metabolismo , Oxidación-Reducción/efectos de los fármacos , Factores de Tiempo , Regulación hacia Arriba/efectos de los fármacos , alfa-Tocoferol/sangre
6.
Kidney Int ; 63(6): 2262-8, 2003 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-12753316

RESUMEN

BACKGROUND: Thioredoxin (TRX) is a stress-inducible thiol-containing protein, which has been shown to be an indicator of oxidative stress in a variety of diseases. The association between oxidative stress and hepatitis C virus (HCV) infection, however, remains unknown in hemodialysis patients. METHODS: We measured serum TRX levels in 85 hemodialysis patients positive for anti-HCV antibodies (age, 60 +/- 1 years old; hemodialysis duration, 17 +/- 1 years; M/F = 57/28) by enzyme-linked immunosorbent assay (ELISA), and examined whether blood TRX may be associated with HCV-related hepatic injury. RESULTS: Serum TRX was significantly higher in hemodialysis patients with HCV infection (112.3 +/- 3.7 ng/mL, N = 85) than in those without HCV infection (69.7 +/- 3.3 ng/mL, N = 59) (age, 69 +/- 2 years old; hemodialysis duration, 6 +/- 1 years; M/F = 32/27, P < 0.01) or normal subjects (28.0 +/- 5.4 ng/mL, N = 9). TRX was significantly correlated with time on hemodialysis (r = 0.27, P = 0.01) in HCV-positive patients, while it was associated with the patient's age in HCV-negative patients (r = 0.42, P < 0.01). Blood TRX was significantly correlated with asparate aminotransferase in patients with HCV infection (r = 0.34, P < 0.01) and without HCV infection (r = 0.46, P < 0.01). However, serum TRX was not associated with blood alanine aminotransferase, a relatively specific marker of hepatic cellular damage, in HCV-infected hemodialysis patients. A significant relationship was found between serum ferritin and TRX (r = 0.25, P = 0.02) and malondialdehyde (MDA) values (r = 0.25, P = 002) in HCV-positive patients. Serum TRX was also higher in the patients receiving weekly iron supplement with HCV infection (135.3 +/- 10.2 ng/mL vs. 110.2 +/- 3.9 ng/mL, P = 0.06) and without HCV infection (91.8 +/- 12.1 ng/mL vs. 65.2 +/- 2.7 ng/mL, P < 0.01). CONCLUSION: There was a greater increase in serum TRX in hemodialysis patients with HCV viremia than without HCV viremia. However, there may not be an association between serum TRX and HCV-related hepatic injury. TRX increased with serum ferritin in HCV-infected patients and further increased by iron infusion. These findings indicate that HCV infection and iron loading may aggravate oxidative stress in dialysis patients.


Asunto(s)
Hepatitis C Crónica/sangre , Fallo Renal Crónico/complicaciones , Diálisis Renal , Tiorredoxinas/sangre , Anciano , Biomarcadores , Femenino , Ferritinas/sangre , Hepatitis C Crónica/complicaciones , Humanos , Hierro/administración & dosificación , Hierro/sangre , Fallo Renal Crónico/sangre , Fallo Renal Crónico/terapia , Masculino , Persona de Mediana Edad , Estrés Oxidativo , Viremia/sangre , Viremia/complicaciones
7.
Rev. int. dermatol. dermocosmét. clín ; 6(3): 122-125, abr. 2003. tab
Artículo en Español | IBECS | ID: ibc-157187

RESUMEN

Antecedentes; El estrés oxidativo es un fenómeno importante en la muerte de los melanocitos en el vitiligo. Recientemente se ha encontrado una acumulación de peróxido de hidrógeno (H2O2) y niveles bajos de catalasa en la epidermis de pacientes con vitiligo. Se han visto pocas alteraciones de los antioxidantes en la sangre de pacientes con vitiligo, excepto una elevación del selenio. No se han realizado estudios sobre el estrés oxidativo hasta ahora, en pacientes con un fototipo VI de piel (clasificación de Fitzpatrick). Objetivo: Estudiar el estado antioxidante en la sangre de pacientes negros con vitíligo generalizado activo. Métodos: Se evaluaron el estado antioxidante total Randox, y las concentraciones de selenio, ferritina, transferrina, ceruloplasmina, tocoferol y retinal en muestras de sangre de los pacientes de piel negra de las indias Occidentales Francesas (de Martinica) con lesiones activas recientes de vitíligo y de 8 voluntarios sanos equiparados en edad y sexo. Resultados: El estado antioxidante total de la sangre y las concentraciones de selenio aumentaron significativamente en los pacientes con vitiligo, en comparación con los controles equiparados en sexo y edad (p<0,01 y p<0,02, respectivamente). No se modificaron significativamente las concentraciones en sangre de ferritina, transferrina, ceruloplasmina, retinol y tocoferol. Conclusiones: Este es el primer trabajo sobre el estado antioxidante global en sangre en el vitíligo. El aumento del estado antioxidante total en sangre observado en pacientes negros fue un resultado inesperado que necesita confirmarse y explicarse por otros estudios. El aumento espontáneo de las concentraciones de selenio podría ser interesante, puesto que este elemento ha sido recomendado en el tratamiento del vitíligo (AU)


No disponible


Asunto(s)
Humanos , Masculino , Femenino , Adulto , Persona de Mediana Edad , Antioxidantes/análisis , Vitíligo/sangre , Vitíligo/diagnóstico , Selenio/administración & dosificación , Selenio/sangre , Estrés Oxidativo , Acatalasia/complicaciones , Acatalasia/diagnóstico , Tiorredoxinas/análisis , Tiorredoxinas/sangre , Ferritinas/análisis , Ferritinas/sangre , Transferrina/análisis , Selenio/metabolismo , Ceruloplasmina/análisis , Vitamina A/sangre , Tocoferoles/sangre , Selenio/uso terapéutico , Compuestos de Selenio/uso terapéutico , Vitíligo/etnología
8.
J Mol Med (Berl) ; 78(1): 55-62, 2000.
Artículo en Inglés | MEDLINE | ID: mdl-10759030

RESUMEN

To determine the therapeutic effect of sulfur amino acid supplementation in HIV infection we randomized 40 patients with antiretroviral therapy (ART; study 1) and 29 patients without ART (study 2) to treatment for 7 months with N-acetyl-cysteine or placebo at an individually adjusted dose according to a defined scheme. The main outcome measures were the change in immunological parameters including natural killer (NK) cell and T cell functions and the viral load. Both studies showed consistently that N-acetyl-cysteine causes a marked increase in immunological functions and plasma albumin concentrations. The effect of N-acetyl-cysteine on the viral load, in contrast, was not consistent and may warrant further studies. Our findings suggest that the impairment of immunological functions in HIV+ patients results at least partly from cysteine deficiency. Because immune reconstitution is a widely accepted aim of HIV treatment, N-acetyl-cysteine treatment may be recommended for patients with and without ART. Our previous report on the massive loss of sulfur in HIV-infected subjects and the present demonstration of the immunoreconstituting effect of cysteine supplementation indicate that the HIV-induced cysteine depletion is a novel mechanism by which a virus destroys the immune defense of the host and escapes immune elimination.


Asunto(s)
Acetilcisteína/uso terapéutico , Síndrome de Inmunodeficiencia Adquirida/tratamiento farmacológico , VIH-1 , Acetilcisteína/administración & dosificación , Síndrome de Inmunodeficiencia Adquirida/sangre , Síndrome de Inmunodeficiencia Adquirida/inmunología , Síndrome de Inmunodeficiencia Adquirida/virología , Administración Oral , Adolescente , Adulto , Antígenos CD/metabolismo , Método Doble Ciego , Femenino , Glutamina/sangre , Humanos , Interleucina-6/sangre , Células Asesinas Naturales/metabolismo , Masculino , Persona de Mediana Edad , Placebos , Albúmina Sérica/metabolismo , Linfocitos T/metabolismo , Tiorredoxinas/sangre , Carga Viral
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA